PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'UMR 1137-IAME, Decision Sciences in Infectious Diseases Control and Care (DeSCID), INSERM, Université de Paris, Paris, France; Université de Paris, Assistance Publique - Hôpitaux de Paris, Service de Virologie, Hôpital Bichat, Paris, France.\', \'ARC Regulatory Ltd., Moneymore, Magherafelt, Northern Ireland, UK.\', \'Université de Paris, Assistance Publique - Hôpitaux de Paris, Service de Virologie, Hôpital Bichat, Paris, France.\', \'STAT-Dx Life, S.L. (a QIAGEN Company), Barcelona, Spain.\', \'QIAGEN Manchester Ltd., UK.\', \'UMR 1137-IAME, Decision Sciences in Infectious Diseases Control and Care (DeSCID), INSERM, Université de Paris, Paris, France; Université de Paris, Assistance Publique - Hôpitaux de Paris, Service de Virologie, Hôpital Bichat, Paris, France. Electronic address: benoit.visseaux@aphp.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(21)00378-710.1016/j.ijid.2021.04.066
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33901651
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all